Q: What were the motivations to create the Regeneron Genetics Center? A: Human genetics is one of the most powerful approaches available in drug discovery and development today. One of the biggest bottlenecks remaining in drug discovery is the identification of well-validated targets. Drugs developed with...
Q: What are some of the key components of the NanostringnCounter Analysis System? What are some of the advantages of the nCounter System over other analytical approaches? A: Our nCounter Analysis System unlocks massive amounts of biological information from tiny samples. The nCounter platform addresses the...
Q: Can you share with us your motivation and interest in antimicrobial resistance and development of rapid diagnostic methods for infectious disease? And why is this so important? A: We are fast approaching a time when antibiotics will no longer work and simple infections may become...
Q: Invitae wants to be the Amazon of genetic testing. What does that exactly mean and what does Invitae do that is different from other companies to achieve this? A: Invitae is proactively driving down the cost of genetic testing in order to make it more...
Q: What attracted you to join Genomic Health and what is your role? A:Genomic Health shifted the paradigm in cancer management, helping over 700,000 patients optimize their treatment decisions, and pioneering a new business model that has been followed by many companies in the last decade....
A: I was attracted to Inivata to help progress a technology I see can make a major impact in improving how we diagnose and manage patients with cancer. The field of liquid biopsy, and ctDNA analysis specifically, is undergoing rapid development and we’re only now...
Q: What were the motivations to create the Oncology Precision Network (OPeN)? A: As we began implementing precision oncology at our hospitals and clinics throughout Intermountain Healthcare, we quickly began to realize that there are certain variants or mutations in a patient’s tumor that we may...
Does Immunotherapy Measure Up to the Hype? Brigitte Ganter, PhD Disclosures | October 27, 2016 Editor’s Note: The emergence of immunotherapy has redefined cancer medicine. Among those who continue to redefine this expanding arena of clinical research, James P. Allison, PhD, of MD Anderson Cancer Center, holds a special place....
The upcoming Personalized Medicine World Conference (PMWC) 2016 Silicon Valley will honor a few exceptional leaders whom have played, and continue to play, a tremendously critical role in shaping our healthcare system, changing it from a general population approach to a personalized and patient-centered care...
UCSC Genomics Institute’s director David Haussler will chair a session on “Data Solutions in Clinical Genomics” at the upcoming Personalized Medicine World Conference (PMWC) 2016 Silicon Valley, co-hosted with Stanford Health Care and UCSF on January 24-27. Professor Haussler shared some of his thoughts with...
